In a recent episode of NSF’s Compliance Unlocked podcast, Brian Cleary, Director of Marketing for NSF Life Sciences, spoke with Dal Pawar, Founder and Managing Director of AssureBio, a specialist recruitment consultancy focused on Quality Assurance professionals and Qualified Persons (QPs).
WATCH THE FULL PODCAST EPISODE HERE
Drawing on years of experience building one of the strongest networks of quality professionals in the life sciences sector, Pawar shared insights into how the talent market has evolved — and what both companies and candidates need to understand about the current environment.
This article highlights several key themes from the conversation, including shifts in the hiring market, the growing importance of audit and remediation expertise, and the role emerging technologies like AI may play in the future of quality careers.
The life sciences talent market has shifted from candidate‑driven to client‑driven
During the COVID‑19 pandemic and its immediate aftermath, many companies experienced intense competition for quality and regulatory talent. Candidates often had multiple offers and significant leverage in negotiations.
That environment has changed.
Today, the balance of power has shifted toward employers, as economic uncertainty and broader industry pressures have slowed hiring while increasing the number of candidates actively seeking roles.
Pawar explained that the market has become far more competitive for candidates than it was only a few years ago.
As a result, companies are receiving significantly higher volumes of applications, which can make it harder to identify the right talent, particularly for senior quality leadership roles or Qualified Person positions.
This shift has introduced a new set of challenges for hiring managers, who must now invest more time and diligence in evaluating candidates and distinguishing genuine expertise from surface‑level experience.
There are a lot of candidates on the market, which actually makes it harder to recruit for quality leadership roles and QP positions.
The evolving demand for Qualified Persons (QPs)
Qualified Persons remain one of the most critical roles in pharmaceutical manufacturing, responsible for certifying that medicinal products meet regulatory and GMP requirements before release.
While Pawar noted a recent decline in short-term contract demand for QP batch certification roles, the role itself remains central to regulatory compliance across the industry.
As regulatory expectations evolve and manufacturing models become more complex, including outsourcing, global supply chains, and advanced therapies, the demand for highly trained and experienced QPs continues to grow.
For professionals pursuing this career path, formal QP training and ongoing professional development remain essential to ensure the depth of technical, regulatory, and ethical understanding required for the role.
We’re seeing increased demand for auditing roles, particularly around GxP compliance and inspection readiness, as companies ask: ‘Are we prepared for the next inspection?'
The disconnect between employers and candidates on hybrid work
Another major tension in the life sciences job market is the growing disconnect between employer expectations and candidate preferences regarding hybrid or remote work.
While many professionals became accustomed to remote flexibility during the pandemic, some pharmaceutical companies are now pushing for more on‑site presence — particularly in regulated environments such as manufacturing or quality operations.
According to Pawar, this misalignment can slow down hiring processes and create friction between companies and prospective candidates.
For organisations recruiting quality professionals, clearly defining expectations around on‑site work, travel, and flexibility has become increasingly important.
Failure to align these expectations early in the hiring process can lead to prolonged recruitment cycles or failed placements.
Personal branding and visibility now influence hiring outcomes
Another theme discussed in the episode is the growing role of professional visibility, particularly through platforms like LinkedIn.
In an increasingly competitive job market, Pawar explained that candidates who actively share insights, demonstrate thought leadership, or engage with the broader quality community can stand out.
This visibility can help hiring managers better understand a candidate’s expertise, perspective, and engagement with industry developments.
While technical competence remains the most important factor in hiring decisions, a strong professional presence can differentiate candidates when many applicants have similar experience on paper.
AI will shape recruitment — but human judgement remains critical
Artificial intelligence is increasingly influencing hiring processes across many industries, including life sciences.
However, Pawar emphasised that while AI tools may help streamline candidate screening and administrative tasks, they cannot replace the nuanced judgement required when evaluating experienced quality professionals.
In highly regulated sectors like pharmaceuticals, leadership roles require a deep understanding of risk, compliance, and organisational culture — factors that are difficult to assess through automated tools alone.
Instead, Pawar believes AI will augment recruitment processes rather than replace the human expertise required to make critical hiring decisions.
Companies risk falling short if they rely too heavily on technology in recruitment. There needs to be a balance.
How quality professionals can future‑proof their careers
For professionals working in quality and regulatory roles, Pawar offered several practical recommendations for remaining competitive in today’s evolving market.
These include:
- Continuously developing technical expertise in GxP compliance and regulatory expectations.
- Building experience in audits, inspections, and remediation projects.
- Developing leadership and communication skills.
- Staying informed about emerging technologies such as AI and digital quality systems.
- Investing in professional development and training.
Organisations are increasingly looking for individuals who demonstrate curiosity, adaptability, and a commitment to ongoing learning.
Professionals who actively invest in their own development are often better positioned to move into senior leadership roles.
A rapidly evolving talent landscape
The pharmaceutical and biotech industry is undergoing significant transformation — from technological innovation to changing regulatory expectations.
These shifts are reshaping the skills and experience companies prioritise when hiring quality and compliance leaders.
As Pawar’s insights illustrate, the talent market for QA and QP professionals is evolving quickly. Organisations that understand these trends will be better positioned to attract and retain the expertise needed to navigate an increasingly complex regulatory landscape.
Dal Pawar is the Founder and Managing Director of AssureBio. Connect with him on LinkedIn here.
WATCH THE FULL PODCAST EPISODE HERE
